» Authors » Zezhong Xiong

Zezhong Xiong

Explore the profile of Zezhong Xiong including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 32
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma S, Wang Z, Xiong Z, Ge Y, Xu M, Zhang J, et al.
Signal Transduct Target Ther . 2025 Mar; 10(1):87. PMID: 40082405
Enhancer RNAs (eRNAs), a subclass of non-coding RNAs transcribed from enhancer regions, have emerged as critical regulators of gene expression; however, their functional roles in prostate cancer remain largely unexplored....
2.
Hao X, Peng H, Chao Z, Wang Y, Xiao Q, Zhang C, et al.
Eur J Surg Oncol . 2024 Nov; 51(1):109381. PMID: 39581156
Objective: To investigate preoperative predictors for selecting different surgical approaches in patients with renal cell carcinoma with inferior vena cava (IVC) tumor thrombus (RCC-IVCTT), and to establish and validate corresponding...
3.
Zhou Q, Ge Y, Ma S, Xiong Z, Wang Y, Li L, et al.
Sci Rep . 2024 Sep; 14(1):22064. PMID: 39333312
Protein Disulfide-Isomerase A2 (PDIA2) is a gene that encodes proteins, responsible for protein folding and modification within cells. The development and course of many disorders are intimately linked to the...
4.
Xiong Z, Ge Y, Ma S, Wang Y, Li L, Chao Z, et al.
Transl Androl Urol . 2024 Aug; 13(7):1219-1227. PMID: 39100834
Background: Multiparametric magnetic resonance imaging (mpMRI) is a commonly used method to diagnose pelvic lymph node metastasis (PLNM) in prostate cancer (PCa) patients, but there are few comparative studies on...
5.
Ge Y, Ma S, Zhou Q, Xiong Z, Wang Y, Li L, et al.
Chin Med J (Engl) . 2023 Nov; 137(15):1844-1856. PMID: 37997674
Background: Although some well-established oncogenes are involved in cancer initiation and progression such as prostate cancer (PCa), the long tail of cancer genes remains to be defined. Goosecoid ( GSC...
6.
Ge Y, Ma S, Zhang J, Xiong Z, Li B, Ma S, et al.
Cancer Med . 2023 Sep; 12(18):19320-19336. PMID: 37676078
Background: Epithelial-mesenchymal transition (EMT) is associated with early recurrence and a poor prognosis in clear cell renal cell carcinoma (ccRCC). Studies have shown that EMT-related genes play an important regulatory...
7.
Li L, Zeng X, Chao Z, Luo J, Guan W, Zhang Q, et al.
Adv Sci (Weinh) . 2023 Aug; 10(27):e2301975. PMID: 37526345
The Warburg effect-related metabolic dysfunction of the tricarboxylic acid (TCA) cycle has emerged as a hallmark of various solid tumors, particularly renal cell carcinoma (RCC). RCC is characterized by high...
8.
Li L, Chao Z, Waikeong U, Xiao J, Ge Y, Wang Y, et al.
J Transl Med . 2023 Feb; 21(1):146. PMID: 36829161
Background: Kidney cancer undergoes a dramatic metabolic shift and has demonstrated responsiveness to immunotherapeutic intervention. However, metabolic classification and the associations between metabolic alterations and immune infiltration in Renal cell...
9.
Ma S, Ge Y, Xiong Z, Wang Y, Li L, Chao Z, et al.
PeerJ . 2023 Feb; 11:e14784. PMID: 36785707
Clear cell renal cell carcinoma (ccRCC) is considered to be related to the worse prognosis, which might in part be attributed to the early recurrence and metastasis, compared with other...
10.
Xiong Z, Ge Y, Xiao J, Wang Y, Li L, Ma S, et al.
Exp Biol Med (Maywood) . 2022 Nov; 248(1):1-13. PMID: 36408742
Prostate cancer (PCa) is one of the malignant tumors of urinary system with a high morbidity. Enhancer RNA is a subclass of long non-coding RNA transcribed from active enhancer regions,...